SINOVAC swings to net income of USD5.1bn for first half of 2021.

M2 EQUITYBITES-December 31, 2021-SINOVAC swings to net income of USD5.1bn for first half of 2021

(C)2021 M2 COMMUNICATIONS http://www.m2.com

Chinese biopharmaceutical company Sinovac Biotech Ltd (NASDAQ:SVA) stated on Thursday its net income of USD5.1bn (USD51.42 per basic and USD44.80 per diluted common share) for the six months ended 30 June 2021.

This marks a rise in earnings when compared with a net loss of USD12.6m (USD0.13 loss per basic and diluted common share) in the prior year period.

Sales of USD11.0bn were reported for the six months ended 30 June 2021, up over USD67.7m in the prior year period, due to higher sales...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT